Magazine Article | May 2, 2022

Is A Key Function To Product Launch Excellence Being Overlooked?

Source: Life Science Leader

By Michaela Scheiner and Elnaz Moghareh

Understandably, most pharmaceutical company leadership teams are doing their very best to do as much as possible with limited resources. As part of the streamlined pinch, smaller companies in certain geographies tend to either leave the medical affairs function off the organizational chart in the early stages of establishment or create a lean medical affairs structure. In larger organizations, while medical affairs may be a fully functioning unit, the team tends to be relied on as an ad hoc service provider, brought in as internal advisers. In both cases, pharma organizations may miss major opportunities to set their new products up for launch excellence by preparing the market and differentiating products from competing ones post-launch.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader